Medtronic plc (MDT) shares were down more than 5% in pre-market trading on Tuesday after the healthcare technology company reported lower third-quarter profit, primarily due to higher expenses.
Net income fell to $1.143 billion, or $0.89 per share, from $1.294 billion, or $1.01 per share a year earlier. Adjusted earnings, which exclude one-time items, came in at $1.750 billion, or $1.36 per share.
Operating profit decreased to $1.464 billion from $1.646 billion last year.
The company's revenue for the period rose 8.7% to $9.017 billion from $8.292 billion a year earlier. On an organic basis, revenue grew 6%.
For full-year 2026, the company reaffirmed its guidance for organic revenue growth of about 5.5% and adjusted EPS of $5.62 to $5.66. This forecast accounts for a potential tariff impact of approximately $185 million; excluding this, it implies adjusted EPS growth of roughly 4.5%.
On Friday, Medtronic shares closed at $99.49, down 1.38%.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.